{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T19:37:36Z","timestamp":1766518656280},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejpb.2017.06.017","type":"journal-article","created":{"date-parts":[[2017,6,17]],"date-time":"2017-06-17T07:15:18Z","timestamp":1497683718000},"page":"221-232","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Alpha ketoglutarate nanoparticles: A potentially effective treatment for cyanide poisoning"],"prefix":"10.1016","volume":"126","author":[{"given":"Shaheen","family":"Sultana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sushma","family":"Talegaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dhruv Kumar","family":"Nishad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aseem","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2017.06.017_b0005","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1046\/j.1365-2125.2003.01892.x","article-title":"Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications","volume":"56","author":"Labiris","year":"2003","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2017.06.017_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-200039010-00001","article-title":"Sustained release drug delivery to the lungs","volume":"39","author":"Hardy","year":"2000","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejpb.2017.06.017_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v20.i5.10","article-title":"Aerosol treatment of cystic fibrosis","volume":"20","author":"Garcia-Contreras","year":"2003","journal-title":"Crit. Rev. Ther. Drug."},{"key":"10.1016\/j.ejpb.2017.06.017_b0020","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/1568009033481895","article-title":"Aerosol therapy for malignancy involving the lungs","volume":"3","author":"Rao","year":"2003","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ejpb.2017.06.017_b0025","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/jac\/dki027","article-title":"Antitubercular inhaled therapy: opportunities, progress and challenges","volume":"55","author":"Pandey","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejpb.2017.06.017_b0030","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1053\/rmed.2001.1276","article-title":"Evolution of dry powder inhaler design, formulation, and performance","volume":"96","author":"Newman","year":"2002","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejpb.2017.06.017_b0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0168-3659(00)00362-X","article-title":"Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerolization performance","volume":"70","author":"Bosquillon","year":"2001","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejpb.2017.06.017_b0040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S1461-5347(98)00099-6","article-title":"Dry powder formulations for pulmonary delivery","volume":"1","author":"Malcolmson","year":"1998","journal-title":"Pharm. Sci. Technol."},{"key":"10.1016\/j.ejpb.2017.06.017_b0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1742-6723.2012.01538.x","article-title":"Review article: management of cyanide poisoning","volume":"24","author":"Reade","year":"2012","journal-title":"Emerg. Med. Australasia"},{"key":"10.1016\/j.ejpb.2017.06.017_b0050","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/0960327107070566","article-title":"Cyanide: critical issues in diagnosis and treatment","volume":"26","author":"Baud","year":"2007","journal-title":"Human Exp. Toxicol."},{"key":"10.1016\/j.ejpb.2017.06.017_b0055","unstructured":"S.I. Baskin, T.G. Brewer, Cyanide poisoning, in: B.G.R Zajtchuk (Ed.), Medical Aspects of Chemical and Biological Warfare, Office of The Surgeon General Department of the Army, USA, 1997, pp. 271\u2013286."},{"key":"10.1016\/j.ejpb.2017.06.017_b0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/occmed\/kqh020","article-title":"The treatment of cyanide poisoning","volume":"54","author":"Cummings","year":"2004","journal-title":"Occupat. Med"},{"key":"10.1016\/j.ejpb.2017.06.017_b0065","article-title":"Effects of \u03b1-ketoglutarate on some hepatic variables altered by cyanide in vivo and in vitro","volume":"6","author":"Tulsawani","year":"2006","journal-title":"J. Cell Tissue Res."},{"key":"10.1016\/j.ejpb.2017.06.017_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.05.001","article-title":"Effect of sub-acute oral cyanide administration in rats: protective efficacy of alpha-ketoglutarate and sodium thiosulfate","volume":"156","author":"Tulsawani","year":"2005","journal-title":"Chem.-Biol. Interact."},{"key":"10.1016\/j.ejpb.2017.06.017_b0075","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-4274(02)00012-7","article-title":"In vitro and in vivo attenuation of experimental cyanide poisoning by \u03b1-ketoglutarate","volume":"128","author":"Bhattacharya","year":"2003","journal-title":"Toxicol. let."},{"key":"10.1016\/j.ejpb.2017.06.017_b0080","unstructured":"J.L. Burstein, D.C. Keyes, R.B. Schwartz, R.E. Swienton, Medical Response to Terrorism, Preparedness and Clinical Practice, Lippincott Williams and Wilkins, 2004, p.33."},{"key":"10.1016\/j.ejpb.2017.06.017_b0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ijpharm.2003.09.041","article-title":"Formulation and characterization of spray dried powders containing nanoparticles for aerosol delivery to the lung","volume":"269","author":"Sham","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.14356\/kona.2004010","article-title":"Particle size analysis of aerosols from medicinal inhalers","volume":"22","author":"Mitchell","year":"2004","journal-title":"KONA. Powder Sci. Technol."},{"key":"10.1016\/j.ejpb.2017.06.017_b0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejps.2005.04.009","article-title":"Microencapsulated chitosan nanoparticles for lung protein delivery","volume":"25","author":"Grenha","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.06.017_b0100","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2007.04.032","article-title":"Nanosizing of a drug\/carrageenan complex to increase solubility and dissolution rate","volume":"342","author":"Dai","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0105","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ejps.2004.12.010","article-title":"Amphiphilic amino acid copolymers as stabilizers for the preparation of nanocrystal dispersion","volume":"24","author":"Lee","year":"2005","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2017.06.017_b0110","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2009.05.006","article-title":"Quality by design approach to understand the process of nanosuspension preparation","volume":"377","author":"Verma","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2009.06.029","article-title":"Effect of wet milling process on the solid state of indomethacin and simvastatin","volume":"380","author":"Sharma","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2009.06.022","article-title":"In vitro and in vivo antitumor activity of oridonin nanosuspension","volume":"379","author":"Lou","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2007.12.016","article-title":"Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions","volume":"355","author":"Gao","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0130","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.powtec.2006.07.016","article-title":"A comparative study of approaches used to improve solubility of roxithromycin","volume":"169","author":"Biradar","year":"2006","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2017.06.017_b0135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2004.03.010","article-title":"A novel spray-drying technique to produce low density particles for pulmonary delivery","volume":"278","author":"Hartwig","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijpharm.2009.08.011","article-title":"Design of porous microparticles with single-micron size by novel spray freeze-drying technique using four-fluid nozzle","volume":"382","author":"Niwa","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijpharm.2008.11.029","article-title":"Development of an oral rutin nanocrystal formulation","volume":"370","author":"Mauludin","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0150","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijpharm.2009.03.013","article-title":"Reginald, preparation and characterization of spironolactone nanoparticles by antisolvent precipitation","volume":"375","author":"Dong","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ijpharm.2008.11.018","article-title":"Enhancement of oral bioavailability of an HIVattachment inhibitor by nanosizing and amorphous formulation approaches","volume":"370","author":"Fakes","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0160","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.powtec.2009.05.029","article-title":"A novel process for precipitation of ultra-fine particles using sub-critical CO2","volume":"195","author":"Dalvi","year":"2009","journal-title":"Powder Tech."},{"key":"10.1016\/j.ejpb.2017.06.017_b0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.supflu.2009.09.006","article-title":"Micronization of drug particles via RESS process","volume":"52","author":"Hezave","year":"2010","journal-title":"The J. Supercrit. Fluids."},{"key":"10.1016\/j.ejpb.2017.06.017_b0170","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijpharm.2009.10.044","article-title":"A combinational supercritical CO2 system for nanoparticle preparation of indomethacin","volume":"386","author":"Tozuka","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2017.06.017_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.powtec.2011.01.012","article-title":"Formulation development and optimization of alpha ketoglutarate nanoparticles for cyanide poisoning","volume":"211","author":"Sultana","year":"2011","journal-title":"Powder Technol."},{"key":"10.1016\/j.ejpb.2017.06.017_b0180","first-page":"411","article-title":"Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic R block copolymers","author":"Kyung","year":"2004","journal-title":"J. Control Rel."},{"key":"10.1016\/j.ejpb.2017.06.017_b0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/jcis.2001.7740","article-title":"Interactions between Surfactants and Particles: Dispersion Surface Modification, and Adsolubilization","volume":"241","author":"Esumi","year":"2001","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ejpb.2017.06.017_b0190","series-title":"Industrial Hygiene and Toxicology: Volume II: Toxicology","first-page":"1512","author":"Patty","year":"1963"},{"key":"10.1016\/j.ejpb.2017.06.017_b0195","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1039\/C4PY00039K","article-title":"E. Pluronic\u00ae block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances","volume":"5","author":"Pitto-Barry","year":"2014","journal-title":"Polym. Chem."},{"key":"10.1016\/j.ejpb.2017.06.017_b0200","first-page":"93","volume":"2","author":"Singh-Joy","year":"2008","journal-title":"Int. J. Toxicol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304824?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641117304824?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T16:27:31Z","timestamp":1535732851000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641117304824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":40,"alternative-id":["S0939641117304824"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.06.017","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha ketoglutarate nanoparticles: A potentially effective treatment for cyanide poisoning","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2017.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}